Chronic systemic inflammation, aging, and obesity have been reported to downregulate FFAR4 expression in osteoclasts and osteoblasts, which may impair the anti-inflammatory and bone-protective actions of DHA in such conditions [62,63]. This evidence concerns the gene FFAR4 and obesity disorder.